Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006
Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998
Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Octreotide Therapy for Thyroid-Stimulation Hormone-Secreting Pituitary Adenomas, A Follow-up of 52 Patients
Ann Int Med 119:236-240, Chanson,P.,et al, 1993
Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Acromegaly
NEJM 322:966-977, Melmed,S., 1990
Analgesic Effect of Somatostatin Analogue (Octreotide) in Headache Associated with Pituitary Tumours
BMJ 295:247-248, Williams,G.,et al, 1987
Response of Thyrotropin-Secreting Pituitary Adenomas to a Long-Acting Somatostatin Analogue
NEJM 317:12-17, Comi,R.J.,et al, 1987
Visual Improvement with SMS 201-995 in a Patient with a Thyrotropin-Secreting Pituitary Adenoma
NEJM 317:53-54, Guillaussea,P.J.,et al, 1987
Improvement in Headache Associated with Prolactinoma During Treatment with a Somatostatin Analogue:An"N of 1"Study
NEJM 315:1166-1167, Williams,G.,et al, 1986